Investors closely tracking Injective, Mirror Protocol, and KangaMoon in Q1 2024

Investors closely tracking Injective, Mirror Protocol, and KangaMoon in Q1 2024

Disclosure: This article does not represent investment advice. The content and materials featured on this page are for educational purposes only.

As investors search for opportunities in 2024, analysts are bullish on Injective (INJ), Mirror Protocol (MIR), and KangaMoon (KANG). 

Injective bulls target new highs

Injective rallied in 2023, adding over 2,000% before peaking at $39.88 on Dec. 19. 

In January, prices broke higher, rising to $45.19. The uptrend momentum has since fizzled. 

INJ is fluctuating between $32.19 and $38.85 in February, dropping in the past week and month. 

Some analysts predict that INJ will reach a new all-time high of $50 by the end of 2024.

Mirror Protocol struggling

Mirror Protocol has been bearish in the past month, fluctuating between $0.01797 and $0.05143. 

Analysts are nonetheless bullish, pointing to the SMAs and Fear & Greed Index are leading indicators. 

The Fear & Greed Index for Mirror Protocol is currently at 60 (Greed), while the token is trading between the 50-Day SMA ($0.056020) and 200-Day SMA ($0.062152). 

Analysts predict MIR to retest $0.061362 in the coming weeks.

KangaMoon bulls confident

KangaMoon is a meme coin trying to build a community of users who enjoy gaming and socializing online. 

KANG, the native token, is used to buy things in the game and upgrade characters. Holders can also participate in challenges to earn more tokens. 

In the ongoing presale, KANG trades for $0.005. Even so, analysts expect KANG prices to rise, riding the expansion in the gaming industry.

Conclusion 

INJ, MIR, and KANG, supporters claim, are worth considering in 2024. KangaMoon, being a meme coin building a vibrant and equitable community, investors claim, may outperform the rest. 

Disclosure: This content is provided by a third party. crypto.news does not endorse any product mentioned on this page. Users must do their own research before taking any actions related to the company.


Follow Us on Google News